Evidence map›Paper›PMID 41070451›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Autochthonous transmission of extensively drug-resistant

Regina Selb, Hana Tlapák, Kathleen Klaper, Susanne Buder, Klaus Jansen, Dagmar Heuer

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Extensively drug-resistant (XDR)Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Regina SelbRobert Koch Institute, Unit of HIV/AIDS, STI and Blood-borne Infections, Department of Infectious Disease Epidemiology, Berlin, Germany.
Hana TlapákRobert Koch Institute, Unit of Sexually Transmitted Bacterial Pathogens and HIV, Department of Infectious Diseases, Berlin, Germany.
Kathleen KlaperRobert Koch Institute, Unit of HIV/AIDS, STI and Blood-borne Infections, Department of Infectious Disease Epidemiology, Berlin, Germany.
Susanne BuderRobert Koch Institute, German Reference Laboratory for Gonococci, Unit of Sexually Transmitted Bacterial Pathogens, Department of Infectious Diseases, Berlin, Germany.
Klaus JansenRobert Koch Institute, Unit of HIV/AIDS, STI and Blood-borne Infections, Department of Infectious Disease Epidemiology, Berlin, Germany.
Dagmar HeuerRobert Koch Institute, Unit of Sexually Transmitted Bacterial Pathogens and HIV, Department of Infectious Diseases, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report four confirmed autochthonously transmitted gonorrhoea cases in Germany in 2025, with

Indexed as

Anti-Bacterial AgentsDrug Resistance, Multiple, BacterialGonorrheaNeisseria gonorrhoeaeAdolescentAdultAzithromycinCefiximeCeftriaxoneFemaleGermanyHumansMaleMicrobial Sensitivity TestsMiddle AgedMultilocus Sequence TypingAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneRNA, Ribosomal, 23Sautochthonous transmissionGermanyNeisseria gonorrhoeaepenA 60.001resistancesexually transmitted infectionsXDR

Identifiers

PMID41070451
PMCPMC12514436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.